Condition (MeSH)
Protein S Deficiency
ClinicalTrials.gov lists 1 trial for Protein S Deficiency or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section
5 sections measured, none recorded · 1 not measured yet · 1 not computed
1 of the 1 trial is tagged with Protein S Deficiency itself; the rest are tagged with a narrower condition beneath it.
When did Protein S Deficiency trials start? (1)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2024 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 1 trial evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Protein S Deficiency trials in? (1)
Shown in this order: phase order.
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
How many Protein S Deficiency trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Protein S Deficiency? (8)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| High Prevalence of Acquired Thrombophilia Without Prognosis Value in Patients With Coronavirus Disease 2019. | Journal of the American Heart Association | 2020 | Yes |
| Protein C and protein S deficiency - practical diagnostic issues. | Advances in clinical and experimental medicine : official organ Wroclaw Medical University | 2013 | Yes |
| Acquired protein S deficiency caused by estrogen treatment of tall stature. | The Journal of pediatrics | 1999 | Yes |
| Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose- und Hamostaseforschung (GTH) Study Group on Natural Inhibitors. | Arteriosclerosis, thrombosis, and vascular biology | 1996 | Yes |
| Prevalence of thrombophilia according to age at the first manifestation of venous thromboembolism: results from the MAISTHRO registry. | British journal of haematology | 2013 | No |
Showing 5 of 8 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.